Back to Search
Start Over
Supplementary Data from Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Data from Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....14baf355a476d7d073f29dbc5976f9f5
- Full Text :
- https://doi.org/10.1158/1078-0432.22487030